BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16333012)

  • 1. Progress in the adjuvant treatment of colon cancer: has it influenced clinical practice?
    Van Cutsem E; Costa F
    JAMA; 2005 Dec; 294(21):2758-60. PubMed ID: 16333012
    [No Abstract]   [Full Text] [Related]  

  • 2. [The adjuvant chemotherapy of obstructive colonic cancer].
    Matviĭchuk BO
    Lik Sprava; 1998; (7):105-7. PubMed ID: 10050474
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant therapy for colon cancer in the new millenium.
    Rao S; Cunningham D
    Scand J Surg; 2003; 92(1):57-64. PubMed ID: 12705552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of fluorouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: a randomised trial. QUASAR Collaborative Group.
    Lancet; 2000 May; 355(9215):1588-96. PubMed ID: 10821362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adjuvant chemotherapy in cancer of the colon].
    Boni C; Pajetta V
    Tumori; 2000; 86(3 Suppl):S20-2. PubMed ID: 10969610
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy in stage II/Duke's B2 colon cancer: tolerable but necessary?
    Brown TD
    Am J Gastroenterol; 1996 Jul; 91(7):1466-7. PubMed ID: 8678023
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation.
    Jessup JM; Stewart A; Greene FL; Minsky BD
    JAMA; 2005 Dec; 294(21):2703-11. PubMed ID: 16333005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant therapy of colorectal cancer.
    Kemeny N; Saltz L; Cohen A
    Surg Oncol Clin N Am; 1997 Oct; 6(4):699-722. PubMed ID: 9309089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. North Central Cancer Treatment Group--Mayo Clinic trials in colon cancer.
    O'Connell MJ
    Semin Oncol; 2001 Feb; 28(1 Suppl 1):4-8. PubMed ID: 11273589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should adjuvant chemotherapy become standard treatment for patients with stage II colon cancer? Against the proposal.
    Köhne CH
    Lancet Oncol; 2006 Jun; 7(6):516-7. PubMed ID: 16767832
    [No Abstract]   [Full Text] [Related]  

  • 12. [Severe myalgias: an unusual undesirable effect of levamisole combined with 5-fluorouracil].
    Buecher B; Blanc JF; Magnien F; Bechade D; Lapprand M; Oddes B
    Gastroenterol Clin Biol; 1996; 20(4):407-8. PubMed ID: 8758514
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant chemotherapy.
    Waters JS; Cunningham D
    Lancet; 2000 Oct; 356(9237):1276. PubMed ID: 11072976
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjuvant chemotherapy for colon cancer: the US experience.
    Haller DG
    Tumori; 2001; 87(1 Suppl 1):S86-8. PubMed ID: 11300040
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimal duration of fluorouracil plus levamisole colon cancer surgical adjuvant therapy.
    O'Connell MJ; Kahn MJ; Erlichman C; Goldberg RM; Shepherd LE
    J Clin Oncol; 1996 Oct; 14(10):2887. PubMed ID: 8874353
    [No Abstract]   [Full Text] [Related]  

  • 16. [Adjuvant treatment for colon carcinoma. Results and perspectives].
    Wein A; Riedel C; Lehnert T; Wakker R; Reingruber B; Teichmann W; Kohnen R; Herfarth C; Hohenberger W; Hahn EG
    Dtsch Med Wochenschr; 1998 May; 123(21):674-80. PubMed ID: 9638096
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of colonic cancer and follow up].
    Belmonte-Montes C; Cosme-Reyes C
    Rev Gastroenterol Mex; 2007 Nov; 72 Suppl 2():122-5. PubMed ID: 18277499
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjuvant chemotherapy in colon cancer: what is the evidence?
    Haydon A
    Intern Med J; 2003 Mar; 33(3):119-24. PubMed ID: 12603585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of immune parameters with clinical outcome in stage III colon cancer: results of Southwest Oncology Group Protocol 9009.
    Holcombe RF; Jacobson J; Dakhil SR; Stewart RM; Betzing KS; Kannan K; Macdonald JS
    Cancer Immunol Immunother; 1999 Dec; 48(9):533-9. PubMed ID: 10602891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of adjuvant chemotherapy in the treatment of colorectal cancer.
    Vaughn DJ; Haller DG
    Hematol Oncol Clin North Am; 1997 Aug; 11(4):699-719. PubMed ID: 9257152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.